Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of TAK-850 versus egg-derived trivalent inactivated influenza vaccine in healthy Japanese adults
jRCT2080222967Phase 2
- Sponsor
- Takeda
- Start
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TAK-850 in seasonal influenza (2 arms), sponsored by Takeda.
02
Drugs
TAK-850
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on jRCT2080222967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222967.